加速康复外科方案在腹腔镜袖状胃切除术中的随机对照试验
该随机对照试验在高容量减重手术中心纳入130例腹腔镜袖状胃切除术患者,对比加速康复外科(ERAS)方案与标准治疗。ERAS组阿片类药物使用更少、疼痛评分更低、出院准备时间更短且术后第1天出院比例更高,30天安全结局无差异。
要点
- ERAS方案可减少腹腔镜袖状胃切除术后阿片类药物使用。
- ERAS方案缩短出院准备时间并提高术后第1天出院率。
- ERAS方案未增加30天不良事件、再入院或急诊就诊。
核心结论
- 与标准治疗相比,ERAS方案与更早出院、更低疼痛评分及更少阿片类药物使用相关,且30天安全结局无差异。
研究设计与样本
- 随机对照试验,纳入2018年3月至2019年1月期间接受腹腔镜袖状胃切除术的患者,最终分析130例(标准治疗组65例,ERAS组65例)。
主要发现
- ERAS组病房内阿片类药物使用比例低于标准治疗组(72.3% vs. 95.4%;p < .001)。
- ERAS组疼痛峰值评分显著更低。
- ERAS组达到出院准备时间的中位数更短(28.0 h vs. 44.4 h;p = 0.001)。
- ERAS组术后第1天出院比例更高(38.5% vs. 15.4%;p < .05)。
- 两组补救性止吐药物总体使用、30天术后事件、再入院及急诊就诊率无差异。
临床怎么用
- 在腹腔镜袖状胃切除术围术期可考虑实施包含术前术后用药方案的ERAS路径,以减少阿片类药物使用并促进早期出院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this study was to evaluate the effect of an enhanced recovery after surgery (ERAS) protocol on opioid and anti-emetic use, length of stay and safety after laparoscopic sleeve gastrectomy (LSG). METHODS: Patients who underwent LSG between March 2018 and January 2019 at our accredited, high-volume bariatric surgery center were randomized to either standard of care (SOC) or ERAS. ERAS included a pre- and post-surgical medication regimen designed to reduce postoperative nausea, vomiting and pain. Outcomes included post-operative symptom scores, opioid use, anti-emetic use, time to achieve readiness for discharge (RFD) and inpatient and 30-day adverse events, readmissions and emergency department visits. RESULTS: The final analysis included 130 patients, (SOC 65; ERAS 65). Groups did not differ on demographics or comorbidities. Relative to SOC, fewer ERAS patients utilized opioids in the hospital ward (72.3% vs. 95.4%; p < .001), peak pain scores were significantly lower, and median time to achieve RFD was shorter (28.0 h vs. 44.4 h; p = 0.001). More ERAS patients were discharged on post-operative day 1 (38.5% vs. 15.4%; p < .05). The overall use of rescue anti-emetic medications was not different between groups. Rates of postoperative 30-day events, readmissions, and emergency department visits did not differ between groups. CONCLUSION: Relative to SOC, ERAS was associated with earlier discharge, lower pain scores, less frequent use of opioids and use in lower amounts after LSG with no differences in 30 day safety outcomes.
引用
- Papasavas P, Seip RL, McLaughlin T, et al. A randomized controlled trial of an enhanced recovery after surgery protocol in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc. 2022. PMID: 36050610. doi:10.1007/s00464-022-09512-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。